Target intelligence / Profile preview

Sprouty-related EVH1 domain-containing protein 1 mRNA 3' untranslated region (SPRED1 mRNA 3' UTR)

Target
SPRED1 mRNA 3' UTR
Molecular classification
RNA, Untranslated region (UTR), Regulatory RNA element
01

Overview

The SPRED1 mRNA 3' untranslated region (3' UTR) is a critical regulatory segment of the SPRED1 transcript that governs the stability and translation of the SPRED1 protein (NCBI Gene ID: 161742). SPRED1 functions as a potent negative regulator of the RAS/MAPK signaling pathway by inhibiting the activation of RAF (UniProt Q96CY2). The 3' UTR contains multiple binding sites for microRNAs, most notably miR-126, which suppresses SPRED1 expression to facilitate processes like angiogenesis and cell migration (Fish et al., 2008, Developmental Cell). Dysregulation of this region, often through microRNA overexpression, is linked to various cancers and cardiovascular conditions where SPRED1 levels are pathologically reduced (PubMed: 23536551). Consequently, the SPRED1 3' UTR is an emerging therapeutic target for RNA-based therapies, such as antagomirs or antisense oligonucleotides, designed to restore SPRED1 levels and normalize RAS signaling in disease states like Legius syndrome (Brems et al., 2007, Nature Genetics).

Other names
SPRED1 3' UTRSprouty-related EVH1 domain-containing protein 1 3' untranslated regionhfl-331 3' UTR
02

Mechanism of action

Modulation of SPRED1 protein expression by interfering with microRNA-mediated repression or mRNA degradation at the 3' UTR binding sites, thereby regulating the RAS/MAPK signaling cascade.

03

Biological functions

Negative regulation of RAS/MAPK signalingPost-transcriptional regulation of gene expressionRegulation of angiogenesisCell proliferation controlmRNA stability regulation
04

Disease associations

Legius syndromeCancerMelanomaHepatocellular carcinomaCardiovascular disease
05

Safety considerations

Off-target effects of microRNA modulatorsPotential for systemic RAS pathway disruptionChallenges in tissue-specific delivery of RNA-based agents
06

Interacting drugs

miR-126 inhibitors (Antagomirs)

4 more in the full profile.

07

Biomarkers

SPRED1 protein expressionPhosphorylated ERK1/2 (p-ERK) levelsmiR-126 expression levelsSPRED1 mRNA stability

Beyond the preview

Go deeper on Sprouty-related EVH1 domain-containing protein 1 mRNA 3' untranslated region (SPRED1 mRNA 3' UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sprouty-related EVH1 domain-containing protein 1 mRNA 3' untranslated region (SPRED1 mRNA 3' UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call